These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25742743)

  • 1. Three dimensional in vitro human tissue models for ADME-Tox studies.
    Chun YJ
    Drug Metab Pharmacokinet; 2014; 29(6):431-432. PubMed ID: 25742743
    [No Abstract]   [Full Text] [Related]  

  • 2. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective.
    Calitz C; Hamman JH; Fey SJ; Wrzesinski K; Gouws C
    Toxicol Mech Methods; 2018 Jun; 28(5):369-385. PubMed ID: 29297242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: "Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals".
    Ulmer WR
    Int J Toxicol; 2003; 22(6):475-6; author response 476-8. PubMed ID: 14680995
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
    Andersson TB
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):234-238. PubMed ID: 28470941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal toxicity: alternative methods for risk assessment.
    Goldberg AM; Maibach HI
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):493-6. PubMed ID: 9599697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Judging the value of 'liver-on-a-chip' devices for prediction of toxicity.
    Starokozhko V; Groothuis GM
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):125-128. PubMed ID: 27724053
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment.
    Kyffin JA; Sharma P; Leedale J; Colley HE; Murdoch C; Mistry P; Webb SD
    Toxicol In Vitro; 2018 Apr; 48():262-275. PubMed ID: 29408671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-content screening technology for studying drug-induced hepatotoxicity in cell models.
    Tolosa L; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2015 Jul; 89(7):1007-22. PubMed ID: 25787152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of hepatotoxicity.
    Meyer SA
    Curr Protoc Toxicol; 2001 Aug; Chapter 14():Unit 14.1. PubMed ID: 23045037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
    Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
    Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.
    Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis.
    Trask OJ; Moore A; LeCluyse EL
    Assay Drug Dev Technol; 2014; 12(1):16-27. PubMed ID: 24444127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CON4EI: CONsortium for in vitro Eye Irritation testing strategy.
    Van Rompay AR; Verstraelen S; Blaauboer BJ
    Toxicol In Vitro; 2018 Jun; 49():1. PubMed ID: 29685209
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro alternatives for ocular irritation.
    Curren RD; Harbell JW
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):485-92. PubMed ID: 9599696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.
    Meng Q
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):733-46. PubMed ID: 20380484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug.
    Meng Q; Zhang G; Shen C; Qiu H
    Toxicol Lett; 2006 Sep; 166(1):19-26. PubMed ID: 16814964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.